Strong therapies, JB to lift Torrent Pharma
A strong performance in the July–September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals. Several brokerages have upgraded the stock of

